This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of neurokinin-1 (NK1) receptor antagonists. These antagonists are crucial in the development of medications aimed at treating conditions such as chemotherapy-induced nausea and vomiting, as well as certain types of depression and anxiety disorders. The specific stereochemistry of the compound ensures high selectivity and efficacy in binding to the NK1 receptor, making it a valuable component in the production of targeted therapeutic agents. Additionally, its structural features contribute to the overall stability and bioavailability of the final drug product, enhancing its effectiveness in clinical applications.